{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:20:27Z","timestamp":1780474827649,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.contraception.2005.08.011","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T12:48:02Z","timestamp":1131022082000},"page":"166-178","source":"Crossref","is-referenced-by-count":47,"title":["Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review"],"prefix":"10.1016","volume":"73","author":[{"given":"Anshu P.","family":"Mohllajee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer L.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert B.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.08.011_bib1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.08.011_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","article-title":"World distribution of factor V Leiden","volume":"346","author":"Rees","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.08.011_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.277.16.1305","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening","volume":"277","author":"Ridker","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2005.08.011_bib4","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2005.08.011_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","article-title":"Geographic distribution of the 20210 G to A prothrombin variant","volume":"79","author":"Rosendaal","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.08.011_bib6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.08.011_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1653730","article-title":"Prevalence of protein C deficiency in the healthy population","volume":"73","author":"Tait","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.08.011_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1994.tb04878.x","article-title":"Prevalence of antithrombin deficiency in the healthy population","volume":"87","author":"Tait","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2005.08.011_bib9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2005.08.011_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00187-1","article-title":"Post-marketing surveillance of Norplant contraceptive implants: II. Non-reproductive health","volume":"63","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.08.011_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.08.011_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0049-3848(98)00028-0","article-title":"Oral contraception and factor V Leiden mutation in relation to localization of deep vein thrombosis","volume":"90","author":"Andersen","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2005.08.011_bib13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.08.011_bib14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-0037-1616136","article-title":"Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism. Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism","volume":"86","author":"Emmerich","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.08.011_bib15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/euhj.2001.3082","article-title":"Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use","volume":"23","author":"Legnani","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.contraception.2005.08.011_bib16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.contraception.2005.08.011_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7326\/0003-4819-135-5-200109040-00008","article-title":"A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism","volume":"135","author":"Middeldorp","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2005.08.011_bib18","first-page":"965","article-title":"Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene","volume":"86","author":"Santamaria","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.contraception.2005.08.011_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-estrogen combined estrogen\u2013progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.08.011_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/13625180008500383","article-title":"Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?","volume":"5","author":"Spannagl","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.08.011_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0037-1613373","article-title":"Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk","volume":"89","author":"Vaya","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.08.011_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0037-1614213","article-title":"Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism","volume":"79","author":"Andersen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.08.011_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2005.08.011_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/01.CIR.0000137123.55051.9B","article-title":"Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities","volume":"110","author":"Martinelli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2005.08.011_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bmj.316.7131.589","article-title":"Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group","volume":"316","author":"de Bruijn","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2005.08.011_bib26","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJM199806183382502","article-title":"High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives","volume":"338","author":"Martinelli","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2005.08.011_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2005.02.008","article-title":"Keeping up with evidence: a new system for WHO's evidence-based family planning guidance","volume":"28","author":"Mohllajee","year":"2005","journal-title":"Am J Prev Med"},{"issue":"3 Suppl","key":"10.1016\/j.contraception.2005.08.011_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2005.08.011_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-0037-1614441","article-title":"The factor V gene A4070G mutation and the risk of venous thrombosis","volume":"81","author":"Alhenc-Gelas","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2005.08.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(98)00136-4","article-title":"The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels","volume":"93","author":"Cattaneo","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2005.08.011_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0015-0282(99)00318-0","article-title":"Screening for factor V Leiden mutation before prescribing combination oral contraceptives","volume":"72","author":"Creinin","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2005.08.011_bib32","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.313.7065.1127","article-title":"Factor V Leiden: should we screen oral contraceptive users and pregnant women?","volume":"313","author":"Vandenbroucke","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2005.08.011_bib33","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2004"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T16:48:02Z","timestamp":1586537282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782405003124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0010782405003124"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.08.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}